Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

ORIX combines strong underlying first-quarter earnings, substantial capital returns and explicit FY2028 targets for higher ROE and AUM. The investment case is nevertheless balanced by the unusually large Kioxia-related contribution to reported earnings.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026
Low · most bearish analyst$41.38
Mean target$41.38
High · most bullish analyst$41.38
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$41.3824%

Kioxia-related valuation effects reverse or obscure weaker recurring performance, while slower capital recycling and asset-management growth cause ORIX to miss its FY2028 ROE and AUM targets. Credit, market, interest-rate and foreign-exchange exposures across the portfolio compound the earnings pressure.

Base CaseCentral scenario
$41.3855%
Matches the consensus mean

Adjusted earnings remain sound and shareholder distributions provide support, but reported FY2027 profit is materially influenced by Kioxia-related gains and progress toward the FY2028 targets remains execution-dependent.

Bull CaseUpside scenario
$41.3821%

ORIX achieves its FY2028 targets of at least 11% ROE and JPY 100 trillion of AUM as third-party capital and recurring fee income reduce capital intensity. Continued adjusted-profit growth, disciplined capital recycling, the authorized buyback and the dividend framework improve per-share outcomes.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • FY2027 first-quarter net income reached JPY 280.8 billion, while adjusted net income excluding Kioxia-related effects was JPY 159.1 billion.
  • Management targets at least 11% ROE and JPY 100 trillion of AUM by FY2028.3, supported by greater use of third-party capital and fee income.
  • Capital returns include a share-repurchase authorization of up to JPY 250 billion and an FY2027 dividend set at the higher of 39% of adjusted EPS or JPY 156.10 per ordinary share.
Sign in / Sign up to read more
Key Investment Risks
  • A substantial portion of FY2027 first-quarter reported profit arose from Kioxia-related gains, increasing earnings-quality and valuation-volatility risk.
  • The FY2028 ROE and AUM goals require successful portfolio rotation, asset-management expansion and disciplined execution across a complex group.
  • ORIX remains exposed to credit deterioration, market-price movements, interest rates, foreign exchange, liquidity and regulatory changes across its financing, investment and operating activities.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.